AETHLON MEDICAL INC (AEMD): Form 8-K filed 2026-09-17

Items reported

Item 1.01: Entry into a Material Definitive Agreement
The company signed a material agreement outside the ordinary course of business, or materially amended one. Typical examples are credit agreements, merger agreements, large supply or licensing contracts and financing arrangements.
Item 5.01: Changes in Control of Registrant
A change in control of the company occurred, for example through an acquisition of a controlling stake.
Item 7.01: Regulation FD Disclosure
The company is making information public under Regulation FD, which requires broad public disclosure of material information shared with certain market participants. Investor presentations and press releases are common. Like Item 2.02, this information is generally "furnished" rather than "filed".
Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.

Type	Description	Document
8-K	FORM 8-K	aethlon_8k.htm
EX-2.1	AGREEMENT AND PLAN OF MERGER AND REORGANIZATION	aethlon_ex0201.htm
EX-4.1	FORM OF PRE-FUNDED WARRANT	aethlon_ex0401.htm
EX-10.1	FORM OF PARENT SUPPORT AGREEMENT	aethlon_ex1001.htm
EX-10.2	FORM OF COMPANY STOCKHOLDER SUPPORT AGREEMENT	aethlon_ex1002.htm
EX-10.3	FORM OF LOCK-UP AGREEMENT	aethlon_ex1003.htm
EX-10.4	FORM OF SUBSCRIPTION AGREEMENT	aethlon_ex1004.htm
EX-10.5	FORM OF CVR AGREEMENT	aethlon_ex1005.htm
EX-99.1	PRESS RELEASE, ISSUED ON SEPTEMBER [16], 2026	aethlon_ex9901.htm
EX-99.2	INVESTOR PRESENTATION, DATED SEPTEMBER 2026	aethlon_ex9902.htm

This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.